Luke Turnock, PhD, a criminologist at the University of Lincoln in the UK who studies enhancement drugs, said he suspects some patients will be happy to pay a premium for experimental peptides that come from a licensed compounding pharmacy
Genetic testing for the following syndromes (if your child has certain dysmorphic features or characteristics): Tuberous Sclerosis Complex, Angelman, PraderWilli, Velocardiofacial, and Smith-Lemli-Opitz syndromes Testing for Mitochondrial Dysfunction and Cerebral Folate Deficiency, metabolic disorders with a high prevalence among individuals with ASD and seizures If supporting clinical characteristics exist, consider testing for other, much more rare metabolic disorders, such as: Succinic Semialdehyde Dehydrogenase Deficiency, Adenylosuccinate lyase deficiency, Creatine Metabolism Disorder, Phenylketonuria, Pyridoxine dependent and responsive seizures, and Urea Cycle Disorders Treatment Options for Seizures Seizures are most commonly treated with anti-epileptic drugs (AEDs), but non-AED treatments are also available
Can compounding address tolerability or formulation concerns
So I went looking elsewhere
Individuals taking medications for diabetes, thyroid disorders, or other metabolic conditions should use AOD-9604 only under medical supervision with appropriate monitoring
